- 积分
- 299
- 威望
- 299
- 包包
- 1702
|
是不是这篇啊??有人发过了~~~& b7 F8 s7 I; A C. Q, A- `
$ n7 I! U0 J7 o, n8 Q1 T: I7 Y/ m诱导的多能干细胞(iPSCs)为艾滋病的治疗提供了希望. t8 Y' T# ^# x$ @: G2 g& u) @
http://www.stemcell8.cn/thread-36638-1-1.html8 L- W- o9 T' m
, c4 I8 q% g/ w1 P% ]% v9 S' W4 y/ d( u0 R8 O5 h
Mol Ther. 2011 Mar;19(3):584-93. Epub 2010 Nov 30.
5 L2 l. Z: B+ D6 @% d6 K
5 N: o1 }- M N8 G4 G( WGeneration of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell-derived Induced Pluripotent Stem Cells.2 [" Y$ e6 k! |# I2 F( W P0 Y1 o
Kambal A, Mitchell G, Cary W, Gruenloh W, Jung Y, Kalomoiris S, Nacey C, McGee J, Lindsey M, Fury B, Bauer G, Nolta JA, Anderson JS.1 q7 {6 q( ?$ _
7 g* |' T; x- _& X- G3 aStem Cell Program, Department of Internal Medicine, University of California, Davis, Sacramento, California, USA." r: ?- a4 z8 k) H; |: Q k
8 G+ c( f6 t( x. E6 F/ G( x1 Y$ DAbstract3 _2 j& }6 R" ~# }
Induced pluripotent stem cells (iPSCs) have radically advanced the field of regenerative medicine by making possible the production of patient-specific pluripotent stem cells from adult individuals. By developing iPSCs to treat HIV, there is the potential for generating a continuous supply of therapeutic cells for transplantation into HIV-infected patients. In this study, we have used human hematopoietic stem cells (HSCs) to generate anti-HIV gene expressing iPSCs for HIV gene therapy. HSCs were dedifferentiated into continuously growing iPSC lines with four reprogramming factors and a combination anti-HIV lentiviral vector containing a CCR5 short hairpin RNA (shRNA) and a human/rhesus chimeric TRIM5α gene. Upon directed differentiation of the anti-HIV iPSCs toward the hematopoietic lineage, a robust quantity of colony-forming CD133(+) HSCs were obtained. These cells were further differentiated into functional end-stage macrophages which displayed a normal phenotypic profile. Upon viral challenge, the anti-HIV iPSC-derived macrophages exhibited strong protection from HIV-1 infection. Here, we demonstrate the ability of iPSCs to develop into HIV-1 resistant immune cells and highlight the potential use of iPSCs for HIV gene and cellular therapies.) _3 V3 @: V+ D6 g$ K
) w5 f- e+ D" C+ ?9 A) ] |
|